Loading
Home
Our Physicians
In-House Services
Our Locations
Request An Appointment
Patient Portal
Careers

Our Features:

  • Studio 10 Gallery
  • Hearing Aids
  • 99% Satisfaction
  • Breakthrough Heart Valve Technique
  • Order Your Physician Directory Online Now!
  • New Location
  • New Administration Building

Archives:

  • Studio 10 Gallery (Archive)
  • When the Heart Aches, Saving Time is Saving Lives - Understanding the Door to Balloon Alliance
  • Tampa Radiology Now Open!
  • Vytorin: The Facts
  • First Surgery in Florida July 2006
  • Orthopaedics, Sports Medicine and Spine Center at Florida Medical Clinic
  • Center for Wound Healing & Hyperbaric Medicine
  • New Surgery takes place of Hip Replacement June 22, 2006
  • Unique Alternative to Total Hip Replacement June 8, 2006
  • Florida Medical Clinic Orthopaedist Introduces Unique Alternative To Total Hip Replacement May 1, 2006
  • Getting to the heart of the matter with Dr. Fontanet
  • Prevention of Atherosclerosis – It’s not just about Lowering Cholesterol
  • Living with Heart Failure
  • Atrial Fibrillation Part I
  • Atrial Fibrillation Part II
  • The Science of Complementary and Alternative Medicine
  • Allergies: A Summary from Dr. Daniel Reichmuth
  • April is Cancer Control Month
Home > Archives > Prevention of Atherosclerosis – It’s not just about Lowering Cholesterol

Prevention of Atherosclerosis – It’s not just about Lowering Cholesterol

The Question Still Arises - How Long Should I take Plavix after Coronary Artery Stent Placement?
Written by:
Hector Fontanet, M.D., FACC
Joan Stelzner, ARNP

fontanet-inset.jpgPlavix (Clopidogrel)
is a medication that is given to patients, along with aspirin, following coronary artery stent placement to prevent blood clot formation on the newly implanted stent. Currently, there is controversy regarding the optimal length of Plavix therapy following coronary artery stenting. Since there are two types of stents, drug-eluting stents (stents coated with a medication designed to prevent re-narrowing of the stented blood vessel as the body heals) and bare metal stents (stents without any coating) there are also two different recommendations regarding length of Plavix therapy.

The American Heart Association in conjunction with the American College of Cardiology issued a statement published in the January 15, 2007 issue of Circulation regarding length of Plavix therapy following coronary artery stenting. The recommendation for Plavix therapy following drug-eluting stent (coated stent) placement is currently one full year. For bare metal stents (non-coated stents), the recommendation for Plavix is at least one month. In other words, if you have received a drug eluting stent, continue Plavix for one year. If you receive a bare metal stent, do not stop taking Plavix for at least one month after implant.

Additionally, patients should never stop Plavix without first checking with their cardiologist and/or cardiology care provider. Interrupting Plavix therapy prematurely can lead to clot formation on the stent resulting in heart attack or even death.

In certain situations, Plavix therapy may need to be interrupted before the recommended length of therapy has been completed. These situations, however, are rare and only your cardiologist and/or cardiology care provider should make this determination on your behalf.

Sources:
http://circ.ahajournals.org/

Click here to learn more information about Dr. Hector Fontanet

Our Story
Foundation Of Caring
Phone Book
Social Networking
Facebook RSS Feed YouTube Twitter C
Clinical Research
Forms
Medical Resource

Return to top of page. | Return to Home.



© 2012 Florida Medical Clinic |  Login  | Privacy Practices  | NPI Numbers